Table 2

		Overall mortality						Mortality from endometrial cancer
	N	Deaths N	5- year survival (95% CI)	Unadjusted HR (95% CI)	P-value	Adjusted HR (95% CI)a	P-value	Deaths N	5-year survival (95% CI)	Unadjusted HR (95% CI)	P-value	Adjusted HR (95% CI)b	P-value
Age
<50	17	1	94% (83-100)	1c		1c		1	94% (83-100)	1c		1c
50-69	164	7	96% (92-99)	0.7 (0.1-5.4)	.700	0.6 (0.1-4.9)	.628	5	97% (94-100)	0.5 (0.1-4.0)	.491	0.5 (0.6-4.2)	.512
70+	89	25	71% (62-81)	5.0 (0.7-37.0)	.114	4.4 (0.6-33.1)	.155	13	84% (76-92)	2.6 (0.3-19.8)	.359	3.9 (0.5-30.5)	.196

Period
1980-1987	126	15	88% (82-94)	1c		1c		9	93% (88-97)	1c		1c
1988-1996	144	18	87% (82-93)	1.1 (0.5-2.1)	.835	0.8 (0.4-1.7)	.580	10	93% (88-97)	1.0 (0.4-2.4)	.982	0.5 (0.2-1.5)	.217

Sector of care
Private	121	9	92% (87-97)	1c		1c		5	96% (92-100)	1c		1c
Public	149	24	84% (77-90)	2.3 (1.1-5.0)	.033	2.0 (0·8-5.0)	.150	14	90% (85-95)	2.4 (0.9-6.7)	.089	3.7 (1.0-14.0)	.054

Risk category
1b Grade 1	117	10	91% (86-96)	1c		1c		3	97% (94-100)	1c		1c
1b Grade 2	45	7	89% (80-98)	1.4 (0.5-4.1)	.543	1.8 (0·6-5.1)	.310	4	91% (82-100)	3.7 (0.8-16.6)	.086	3.3 (0.7-15.4)	.122
1b Grade 3	19	4	78% (58-98)	2.8 (0.9-8.8)	.087	5.1 (1.3-19.8)	.017	4	78% (58-98)	9.1 (2.0-40.7)	.004	8.8 (1.9-40.1)	.005
1c Grade 1	63	8	87% (78-96)	1.6 (0.6-4.0)	.331	1.3 (0.5-3.3)	.565	3	95% (89-100)	2.0 (0.4-9.8)	.401	1.0 (0.8-16.8)	.981
1c Grade2	26	6	77% (61-93)	2.8 (1.0-7.7)	.046	2.0 (0.7-5.6)	.185	5	81% (65-96)	7.7 (1.8-32.1)	.005	3.8 (0.8-16.8)	.083

^aAdjusted for age (continuous), sector of care and risk category. ^bAdjusted for age (continuous), risk category and radiotherapy. ^cReference category.

Table 2: Number of deaths, overall and five-year disease-specific survival and all cause mortality and endometrial cancer mortality risks according to patient and tumour characteristics.